Amgen Inc. (AMGN) Collaborates on Ending Anti-OX40 Clinical Studies [Yahoo! Finance]
Amgen Inc. (AMGN)
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amgen.com
Company Research
Source: Yahoo! Finance
We recently compiled a list of the 11 Best Kid-Friendly Stocks to Invest In . Amgen Inc. (NASDAQ:AMGN) is one of the best kid-friendly stocks on our list. On March 3, TheFly reported that Kyowa Kirin Co., Ltd. disclosed that it is discontinuing all ongoing clinical trials involving rocatinlimab, an experimental anti-OX40 monoclonal antibody that was previously being tested for moderate-to-severe asthma, prurigo nodularis, and moderate-to-severe atopic dermatitis. The action follows a scheduled safety assessment within the global development program conducted with Amgen Inc. (NASDAQ:AMGN). The latest review highlighted newly emerging safety issues, including additional malignancy cases with potential viral or immune associations, such as confirmed and suspected instances of Kaposi's sarcoma. Amgen Inc. (AMGN) Collaborates on Ending Anti-OX40 Clinical Studies Although the total number of malignancy events across studies remained below expected background levels, the pattern of th
Show less
Read more
Impact Snapshot
Event Time:
AMGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
News
- Amgen Inc. (AMGN): Billionaire Ken Fisher Doubles Bullish Position [Yahoo! Finance]Yahoo! Finance
- Amgen's TrumpRx Discounts and Dividend Hike Might Change The Case For Investing In Amgen (AMGN) [Yahoo! Finance]Yahoo! Finance
- Amgen and GSK said to be adding products on TrumpRx [Seeking Alpha]Seeking Alpha
- 4 Biotech Stocks to Watch for Potential Upside in 2026 [Yahoo! Finance]Yahoo! Finance
- Two major drug companies are the latest to join TrumpRx [FOX Business Network]FOX Business Network
AMGN
Earnings
- 2/3/26 - Beat
AMGN
Sec Filings
- 3/6/26 - Form 4
- 3/5/26 - Form 4
- 3/5/26 - Form 4
- AMGN's page on the SEC website